Reliance Chemotex Industries Ltd is Rated Sell

11 hours ago
share
Share Via
Reliance Chemotex Industries Ltd is rated 'Sell' by MarketsMojo, with this rating last updated on 25 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 January 2026, providing investors with the latest insights into the company’s performance and outlook.
Reliance Chemotex Industries Ltd is Rated Sell



Current Rating Overview


MarketsMOJO currently assigns Reliance Chemotex Industries Ltd a 'Sell' rating, reflecting a cautious stance on the stock. This rating was revised from 'Strong Sell' on 25 August 2025, accompanied by a modest improvement in the Mojo Score from 29 to 32. Despite this slight positive shift, the overall assessment remains negative, signalling that investors should approach the stock with prudence given prevailing market and company-specific conditions.



How the Stock Looks Today: Key Fundamentals and Metrics


As of 19 January 2026, Reliance Chemotex Industries Ltd remains a microcap player within the Garments & Apparels sector. The company’s Mojo Score of 32.0 and corresponding 'Sell' grade reflect a combination of factors across quality, valuation, financial trend, and technical outlook.



Quality Assessment


The quality grade for Reliance Chemotex is below average, indicating challenges in its fundamental strength. The company’s average Return on Capital Employed (ROCE) stands at 9.25%, which is modest and suggests limited efficiency in generating returns from its capital base. Over the past five years, net sales have grown at an annualised rate of 8.44%, while operating profit has expanded at 17.83% annually. Although these growth rates show some positive momentum, they are not sufficiently robust to elevate the company’s quality standing within its sector or against broader market benchmarks.



Valuation Perspective


Valuation is currently very attractive for Reliance Chemotex Industries Ltd. This suggests that the stock is priced at a discount relative to its earnings potential and asset base, offering a potential value opportunity for investors willing to accept the associated risks. However, attractive valuation alone does not offset concerns arising from other parameters such as financial health and technical trends.



Financial Trend and Stability


The financial grade is positive, reflecting some encouraging signs in the company’s recent financial trajectory. Nevertheless, the company faces a high Debt to EBITDA ratio of 4.66 times, indicating a significant debt burden that could constrain operational flexibility and increase financial risk. This elevated leverage level warrants caution, as it may impact the company’s ability to service debt, especially if earnings fluctuate.



Technical Outlook


Technically, the stock is rated bearish. Price performance data as of 19 January 2026 shows a downward trend with the stock declining by 2.11% on the day, 6.99% over the past week, and 7.99% in the last month. More notably, the stock has delivered a negative return of 37.08% over the past year and has underperformed the BSE500 index over the last three years, one year, and three months. This persistent underperformance highlights weak market sentiment and technical pressure on the stock.



Stock Returns and Market Performance


The latest data shows that Reliance Chemotex Industries Ltd has struggled to generate positive returns for investors. The one-year return of -37.08% is a significant underperformance relative to broader market indices. Year-to-date, the stock has declined by 6.33%, reflecting ongoing challenges in regaining investor confidence. The six-month return of -33.69% and three-month return of -20.89% further underscore the stock’s bearish momentum.



Long-Term Fundamental Strength and Growth


Reliance Chemotex’s long-term fundamental strength is weak. The company’s average ROCE of 9.25% is below industry averages, and its growth in net sales and operating profit, while positive, has not translated into sustainable competitive advantage or superior returns. The high debt levels exacerbate concerns about the company’s financial resilience, especially in a sector that can be cyclical and sensitive to economic fluctuations.



Implications for Investors


For investors, the 'Sell' rating indicates that Reliance Chemotex Industries Ltd currently presents more risks than rewards. The combination of below-average quality, high leverage, bearish technical signals, and negative recent returns suggests that the stock may continue to face headwinds in the near term. While the valuation is attractive, it is important to weigh this against the company’s financial and operational challenges before considering any investment.




Only 1% make it here. This Large Cap from the Gems, Jewellery And Watches sector passed our rigorous filters with flying colors. Be among the first few to spot this gem!



  • - Highest rated stock selection

  • - Multi-parameter screening cleared

  • - Large Cap quality pick


View Our Top 1% Pick →




Sector Context and Market Position


Operating within the Garments & Apparels sector, Reliance Chemotex Industries Ltd faces competitive pressures from both domestic and international players. The sector is characterised by fluctuating demand patterns, evolving consumer preferences, and margin pressures. The company’s microcap status further limits its ability to leverage economies of scale or invest heavily in innovation and marketing compared to larger peers.



Conclusion: What the Sell Rating Means


The 'Sell' rating from MarketsMOJO reflects a comprehensive evaluation of Reliance Chemotex Industries Ltd’s current standing. It signals that the stock is expected to underperform relative to the broader market and that investors should consider reducing exposure or avoiding new positions at this time. The rating is grounded in a balanced analysis of quality, valuation, financial trends, and technical factors, providing a clear framework for decision-making.



Investors should monitor the company’s financial health closely, particularly its debt levels and operational performance, while also keeping an eye on sector developments that could impact future prospects. Until there is a marked improvement in fundamentals and technical indicators, the cautious stance embodied by the 'Sell' rating remains justified.






{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News